Beyond Quantitation: Uncover Structural Complexity Without Sacrificing Sensitivity
App Note / Case Study
Published: September 17, 2026
Brought to you by
SCIEX
SCIEX empowers customers to solve the most impactful analytical challenges in quantitation and characterization. For over 50 years, SCIEX has been at the forefront of the field with groundbreaking innovation, reliability, and support. Since the launch of the first-ever commercially successful triple quadrupole in 1981, their technologies and solutions have influenced life-changing research and outcomes. Thousands of life science experts worldwide rely on SCIEX to get the answers they can trust.
Credit: iStock.
Metabolomics and lipidomics researchers increasingly need more than accurate quantitation. Resolving isomeric species, identifying structural differences, and detecting low-abundance analytes are critical for generating meaningful biological insights. However, many analytical workflows force a compromise between quantitative performance and structural characterization.
This application note explores how a single-injection qual/quant approach can deliver high-sensitivity quantitation alongside rich structural information, enabling more confident analysis of complex metabolites and lipid mediators across diverse biological matrices.
Download this application note to discover:
- How to achieve high-sensitivity quantitation while simultaneously capturing structural information in a single workflow.
- Strategies for resolving isomeric and isobaric compounds that traditional fragmentation approaches struggle to differentiate.
- Approaches for improving confidence in metabolomics and lipidomics studies through enhanced sensitivity, matrix versatility, and streamlined analysis.
SCIEX.com 1
Beyond quantitation
How do you uncover structural
complexity without
sacrificing sensitivity?
The evolving needs of omics research
In today’s metabolomics and lipidomics landscape,
researchers are no longer satisfied with just
detecting and quantifying molecules. They must also
understand their significance. This means not only
measuring low-abundance analytes with precision
but also resolving isomeric species and extracting
structural insights that can drive biological discovery.
Traditionally, triple quadrupole (TQ) mass
spectrometry has been the standard for quantitation,
delivering high sensitivity and reproducibility.
However, its limited ability to provide structural
insights leaves a gap in workflows, one that
high-resolution mass spectrometry (HRMS) has
struggled to close due to sensitivity constraints.
The SCIEX ZenoTOF 8600 system changes
that. By combining TQ-level quantitation with
high-resolution MS/MS and electron-activated
dissociation (EAD) for structural characterization,
it enables a new generation of qual/quant
workflows, all from a single injection.
A new era of qual/quant workflows
The ZenoTOF 8600 system ushers in a new
generation of high-resolution mass spectrometry,
purpose-built for researchers who demand
uncompromising performance in both quantitative
precision and structural insight. By combining
the quantitative capabilities of the SCIEX 7500+
triple quadrupole system with the versatility
and depth of HRMS, the ZenoTOF 8600 system
provides a unified platform for simultaneous
qual/quant workflows, without compromise.
Discover how the ZenoTOF 8600 system
delivers TQ-grade quantitation plus EAD-driven
structural insight in a single injection.
The SCIEX ZenoTOF 8600 system enables
a new generation of simultaneous
qualification and quantitation
workflows, all from a single injection
P R O O F P O I N TSCIEX.com 2
Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
TQ-level quantitation meets
HRMS versatility
At the heart of the ZenoTOF 8600 system is a
reimagined architecture that integrates key
innovations from the SCIEX 7500+ system:
• OptiFlow Pro ion source: A universal source
for all flow regimes (100 nL/min to 3 mL/min),
enabling seamless transitions between highthroughput and high-sensitivity workflows. Its
dual probe ports and calibration sprayer ensure
consistent mass accuracy and uptime.
• DJet and QJet ion guides: Dual-stage ion optics,
adapted from the SCIEX 7500+ system, dramatically
improve ion capture and transmission. This results in
up to 10x sensitivity gains at standard flow rates and
2.5–5x improvements at nanoflow, ensuring robust
quantitation even for low-abundance analytes.
• Mass Guard technology: A high-mass cutoff
filter (T Bar electrodes) protects critical ion
optics from contamination, extending system
robustness and enabling 4x longer matrix tolerance
compared to previous QTOF platforms.
These features, proven in the most sensitive SCIEX TQMS,
now empower HRMS users with TQ-grade quantitation,
but with the added benefit of full-scan MS/MS data.
Zeno trap: The sensitivity multiplier
Traditional QTOFs suffer from low duty cycles,
with only 5–25% of ions reaching the detector. The
Zeno trap revolutionizes this by synchronizing ion
release with TOF pulses, achieving >90% duty cycle
and delivering up to 20x more MS/MS signal.
This innovation is especially impactful for:
• Low-abundance analytes, where every ion counts.
• MS/MS-based quantitation, enabling lower
LLOQs and broader dynamic range.
• Data-independent acquisition (DIA) and
data-dependent acquisition (DDA), where
speed and sensitivity are critical.
EAD: Structural clarity at speed
The electron-activated dissociation (EAD) cell
in the ZenoTOF 8600 system is a game-changer
for structural elucidation. Unlike traditional CID,
EAD utilizes tunable electron energies to generate
rich, diagnostic fragments, which are ideal for
resolving isomers, localizing modifications,
and characterizing labile compounds.
Key advantages include:
• High-speed EAD: Compatible with UHPLC
timescales, EAD can be performed in
the same injection as CID, enabling
routine structural analysis.
• Enhanced sensitivity: The system’s
improved ion optics and detection bring
low-abundance EAD fragments out of the
noise, making EAD viable for lipidomics,
metabolite ID, and oligonucleotide analysis.
• Versatility: Supports a wide range of
fragmentation regimes (such as ECD, EIEIO,
EID), expanding the scope of analytes that
can be confidently characterized.
better sensitivity across scan modes
compared to previous SCIEX instrument
improvement in linear
dynamic range [LDR]
10x
4x
Advanced detection for
high-fidelity data
The ZenoTOF 8600 system features a
4-channel optical detection system with
photomultiplier tubes (PMTs), replacing
traditional MCP stacks. This design delivers:
• Extended detector lifetime (~5 years).
• 4x improvement in linear dynamic range (LDR).
• Lower detection thresholds and enhanced
quantitation accuracy, even under high ion flux.
These capabilities converge to create a platform
that empowers researchers to perform quantitative
and qualitative analysis in a single injection, without
compromising sensitivity, specificity, or throughput.SCIEX.com 3
Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
Bile acids (BAs) are structurally similar
metabolites that play critical roles in
digestion, signalling, and disease pathology.
Their analysis is complicated by the presence
of isobaric and isomeric species, requiring
both chromatographic and MS/MS resolution.
The study demonstrated the application of the
ZenoTOF 8600 system for the comprehensive analysis
of bile acids (BAs) across various biological matrices.
It highlights the system’s ability to deliver highresolution MS/MS data with sensitive quantitation
comparable to triple quadrupole systems, while
also enabling structural elucidation through EAD.
Methodology
Sample types: Plasma, fecal extracts,
liver, and ileal tissue.
Sample prep: Included dried fecal spot (DFS) collection
and standard LC-MS/MS extraction protocols.
Instrumentation: ZenoTOF 8600 system
with EAD and Zeno trap enabled.
Chromatography: Optimized LC separation
to resolve isobaric and isomeric BAs.
MS acquisition: High-resolution MS/MS with
narrow XIC windows and EAD fragmentation.
Case study
Bile acids: Precision in complexity
Figure 1. Detection and quantitation of bile acid isomers in human
plasma using EAD. Using a fast 10-minute gradient, bile acids were
analyzed on the ZenoTOF 8600 system. Isomers such as GCOCA and
GDCA are indistinguishable using CID-based fragmentation. Using
EAD, unique diagnostic fragments enable accurate quantitation
even with chromatographic overlap. The upper panels show two
isomers overlapping, while the lower panels demonstrate the ability
to isolate each isomer when a unique EAD-based fragment is applied.
Intensity
GCDCA
472.3044/472.3044
3.678
Time, min
2.8
0
5000
10000
15000
3.0 3.2 3.4 3.6 3.8 4.0
Intensity
472.
2.8
0
5000
10000
15000
Intensity
472.3044/316.1887
3.693
Time, min
2.8
0
100
80
60
40
20
3.0 3.2 3.4 3.6 3.8 4.0
Intensity
472
2.5
0
40
20
60
80
Intensity
GCDCA
472.3044/472.3044
3.678
Time, min
2.8
0
5000
10000
15000
3.0 3.2 3.4 3.6 3.8 4.0
Intensity
GDCA
472.3044/472.3044
3.799
Time, min
2.8
0
5000
10000
15000
3.0 3.5 4.0
Intensity
472.3044/316.1887
3.693
Time, min
2.8
0
100
80
60
40
20
3.0 3.2 3.4 3.6 3.8 4.0
Intensity
472.3044/262.1407
3.802
Time, min
2.5
0
40
20
60
80
3.0 3.5 4.0SCIEX.com 4
Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
Key findings
Quantitative sensitivity
Using the ZenoTOF 8600 system, researchers
achieved up to 20-fold improvements in MS/
MS sensitivity for small molecules, such as bile
acids, comparable to high-end TQ instruments.
This enabled baseline resolution and accurate
quantitation of isobaric BA pairs such as
UDCA, CDCA, and DCA, which share precursor
ions but differ in diagnostic fragments.
• Achieved baseline resolution and
accurate quantitation of isobaric bile
acids (such as UDCA, CDCA, DCA)
Structural confidence with EAD
Tauro- and glyco-conjugated bile acids (such
as TUDCA, TCDCA, TDCA) share common MRM
transitions (such as m/z 498 › 80), making
them difficult to distinguish using conventional
fragmentation. EAD provided complementary
fragmentation that revealed diagnostic ions,
enabling confident identification of these isomers.
• Enabled differentiation of tauro- and
glyco-conjugated BAs sharing
common MRM transitions
Matrix versatility
The workflow was validated across plasma, fecal
extracts, liver, and ileal tissue, demonstrating
its robustness in diverse biological matrices. In
microbiome studies, dried fecal spot (DFS) analysis
yielded results nearly identical to those of standard
sample preparation, with the added benefit of
ambient temperature shipping and storage, making
it ideal for large-scale or remote studies.
• DFS-based analysis yielded results
comparable to standard prep, with benefits
for ambient shipping and storage
Clinical relevance
In a study of intrahepatic cholestasis of pregnancy
(IHCP), the system detected significantly elevated
levels of specific bile acids (such as GCDCA,
TCDCA, GCA, TCA) in patient plasma. These findings
support the potential of bile acid profiling as a
biomarker strategy for fetal risk assessment.
• IHCP: Elevated levels of specific BAs (such as
GCDCA, TCDCA) detected in patient plasma
• MVID: Altered BA distribution observed
in a myosin 5B knockout mouse model,
linked to transporter mislocalization
Key takeaway
The ZenoTOF 8600 system
enables high-sensitivity, highresolution quantitation and
structural characterization of
bile acids in complex matrices,
all from a single injection, making
it a powerful workflow for both
clinical and microbiome research.
Why it matters
• Quantitation: Achieves TQ-level sensitivity with
up to 20x MS/MS signal boost via the Zeno trap
• Structural insight: EAD fragmentation resolves
isomeric bile acids that share common transitions
• Matrix flexibility: Proven across
plasma, feces, liver, and ileum, including
dried fecal spot (DFS) formats
• Clinical utility: Supports biomarker discovery
in conditions like IHCP and mechanistic
studies in rare diseases like MVID
Find out more
Application note: Quantitative and qualitative bile acid
analysis on the ZenoTOF 8600 system using EADSCIEX.com 5
Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
Oxylipins, a diverse class of bioactive lipid
mediators derived from polyunsaturated
fatty acids, play a central role in
inflammation, immunity, and vascular
biology. Their low abundance and structural
complexity, especially the prevalence
of regio- and stereoisomers, make
them notoriously difficult to analyze.
The study evaluated the ZenoTOF 8600 system for the
quantitation and structural analysis of 70 oxylipins,
a class of bioactive lipid mediators. It demonstrates
the system’s ability to deliver ultra-low LLOQs and
resolve isomeric species using EAD fragmentation.
Methodology
Analytes: 70 oxylipins, including prostaglandins,
leukotrienes, HETEs, and EETs.
Sample prep: Standard mixtures prepared
in neat solvent; LC-MS grade solvents
selected for low background.
Chromatography: Reversed-phase
LC with a 20-minute gradient.
MS acquisition:
• Quantitation via scheduled MRMHR with CID
• Structural analysis via EAD in positive ion mode
• Data processed using SCIEX OS software
4.0 with peak-to-peak S/N calculations
per new oxylipin guidelines
Key findings
Quantitative sensitivity
The ZenoTOF 8600 system quantified 70 oxylipins in
a single workflow, achieving LLOQs as low as 0.0864
pg/μL (0.43 pg on-column) for 20-OH-LTB4 and
0.0329 pg/μL (1.645 pg on-column) for 14,15-DiHETrE.
These results demonstrate TQ-level sensitivity
with the added benefit of full MS/MS acquisition.
• LLOQs as low as 0.0864 pg/μL (0.43
pg on-column) for 20-OH-LTB4
• 14,15-DiHETrE detected at 0.0329
pg/μL (1.645 pg on-column)
Values determined without any smoothing as per
guidelines for oxylipin analysis
https://www.science.org/doi/10.1126/
scisignal.adw1245
Structural elucidation with EAD
Traditional CID fragmentation failed to distinguish
isomeric oxylipins, such as 11-HETE and 11,12-EET,
which shared identical fragmentation patterns. EAD,
however, generated ~15x more fragments, including
unique diagnostic ions (such as m/z 231.0984
for 11,12-EET and m/z 245.1152 for 11-HETE),
enabling confident structural assignment without
relying solely on chromatographic separation.
• CID failed to distinguish isomers
like 11-HETE and 11,12-EET
• EAD generated unique diagnostic fragments
(such as m/z 231.0984 for 11,12-EET),
enabling confident isomer resolution
Workflow efficiency
The ability to acquire quantitative and qualitative
data in a single injection streamlines analysis
and reduces instrument time. The use of narrow
XIC windows further minimized background
interference, enhancing specificity and
lowering LLOQs, even in complex matrices.
• Single-injection qual/quant workflow with
full MS/MS spectra acquisition and narrow
XIC windows for improved specificity
Case study
Lipid mediators: Decoding the oxylipin landscapeFind out more
Application note: Quantitative and qualitative analysis
of oxylipins using high-resolution mass spectrometry
SCIEX.com 6
Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
Key takeaway
The ZenoTOF 8600 system delivers
ultra-sensitive quantitation and
confident isomer resolution of
oxylipins in a single, streamlined
workflow, ideal for lipidomics
and inflammation research.
Why it matters
• Quantitation: Achieves LLOQs as low as 0.43
pg on-column—comparable to high-end TQ
• Qual/quant integration: Full MS/MS spectra
acquired during quantitation enable postacquisition structural verification
• EAD differentiation: Distinguishes regioand stereoisomers (such as 11-HETE vs.
11,12-EET) that CID cannot resolve
• Workflow efficiency: One injection, one
method, no need to compromise between
sensitivity and structural clarity
Figure 1. Standard curve for 20-hydroxy-leukotriene B4 (20-OH-LTB4). Compound analysis was performed in the negative
ion mode using the ZenoTOF 8600 system with reversed-phase chromatography.The LLOQ (0.0869 pg/μL; green box) was
defined as the lowest injected standard with a peak-to-peak signal-to-noise (S/N) ratio > 5; the region where noise was
calculated is shaded grey in the example chromatograms. Quantitive statistics are derived from n = 3 to 5 replicates.
20-OH-LTB4
98.8
pg/µL
Y = 103292 x - 724
r2 = 0.99747 [weighting:1: 1/x]
Log Concentration
5 0
-1.9 -1.8 -1.7 -1.6 -1.5 -1.4 -1.3 -1.2 -1.1 -1.0 -0.9 -0.8 -0.7 -0.6 -0.5 -0.4 -0.3 -0.2 -0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9
Time, min
5.5
2.0e6
1.5e6
1.0e6
5.0e5
0.0e5
6.0
5.60
9.88
pg/µL
Time, min
5.5
1.5e5
1.0e5
5.0e4
0.0e4
6.0
2.0e6 5.69
1.5e6
1.0e6
5.0e5
0.0e5
0.329
pg/µL
Time, min
5.5
7000
6000
5000
4000
3000
2000
1000
0
6.0
5.79
0.329
pg/µL
Time, min
5.5
700
600
500
400
300
200
100
0
6.0
5.69
0.00864
pg/µL
Time, min
5.5
400
300
200
100
0
6.0
5.67
Blank
Time, min
5.5
250
200
150
100
50
0
6.0
0.0864
pg/µL
Time, min
5.5
1500
1000
500
0
6.0
5.09
0.864
pg/µL
Time, min
5.5
15000
10000
5000
0
6.0
5.87
20-OH-LTB4
98.8
pg/µL
Y = 103292 x - 724
r2 = 0.99747 [weighting:1: 1/x]
Log Concentration
5 0
-1.9 -1.8 -1.7 -1.6 -1.5 -1.4 -1.3 -1.2 -1.1 -1.0 -0.9 -0.8 -0.7 -0.6 -0.5 -0.4 -0.3 -0.2 -0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9
Time, min
5.5
2.0e6
1.5e6
1.0e6
5.0e5
0.0e5
6.0
5.60
9.88
pg/µL
Time, min
5.5
1.5e5
1.0e5
5.0e4
0.0e4
6.0
2.0e6 5.69
1.5e6
1.0e6
5.0e5
0.0e5
0.329
pg/µL
Time, min
5.5
7000
6000
5000
4000
3000
2000
1000
0
6.0
5.79
0.329
pg/µL
Time, min
5.5
700
600
500
400
300
200
100
0
6.0
5.69
0.00864
pg/µL
Time, min
5.5
400
300
200
100
0
6.0
5.67
Blank
Time, min
5.5
250
200
150
100
50
0
6.0
0.0864
pg/µL
Time, min
5.5
1500
1000
500
0
6.0
5.09
0.864
pg/µL
Time, min
5.5
15000
10000
5000
0
6.0
5.87
Component name Actual concentration
[pg/μL]
Calculated
concentration [pg/μL]
On column
[pg] STD dev % CV Average accuracy [peak to peak) S/N
20-OH-LTB4 0.00864 0.01260 0.0432 0.00349 27.8 127 1.42
20-OH-LTB4 0.03290 0.03454 0.16450 0.00302 8.73 105 3.92
20-OH-LTB4 0.08640 0.07589 0.43200 0.00627 7.97 91 10.5
20-OH-LTB4 0.03290 0.29400 0.16450 0.01200 4.08 89.4 39.4
20-OH-LTB4 0.86400 0.80490 4.320000 0.01578 1.96 93.2 84.8
20-OH-LTB4 9.8800 8.5770 49.40000 0.1768 2.06 86.8 545
20-OH-LTB4 98.800 100.20 494.000 2.015 2.01 101 1370Beyond quantitation
Unlocking structural insights with the ZenoTOF 8600 system
Enabling a new generation
of omics research
Together, these case studies demonstrate how
the ZenoTOF 8600 system delivers on its promise
of high-sensitivity quantitation, structural
clarity, and workflow efficiency. Whether profiling
bile acids in clinical samples or decoding the
oxylipin landscape in inflammation research,
the system empowers researchers to:
• Quantify with confidence at ultra-low levels.
• Resolve isomers with EAD-enhanced MS/MS.
• Analyze diverse matrices with
minimal method adaptation.
• Accelerate discovery with singleinjection qual/quant workflows.
The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please
contact your local sales representative or refer to https://sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic
Procedures. Trademarks and/or registered trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners in the United
States and/or certain other countries. © 2025 DH Tech. Dev. Pte. Ltd. MKT-36583
Redefining discovery in
small molecule omics
The ZenoTOF 8600 system is more than a mass
spectrometer; it’s a workflow enabler. Uniting
quantitative precision with qualitative depth
allows researchers to move beyond detection
and into true molecular understanding.
In an era where biological complexity demands more
from analytical platforms, the ZenoTOF 8600 system
stands out as a transformative tool for small molecule
omics, delivering the proof points that matter most.
Take the next step
Access full data sets and explore additional
workflows to evaluate the ZenoTOF 8600
system’s performance in your research.
Sponsored by
SCIEX
SCIEX empowers customers to solve the most impactful analytical challenges in quantitation and characterization. For over 50 years, SCIEX has been at the forefront of the field with groundbreaking innovation, reliability, and support. Since the launch of the first-ever commercially successful triple quadrupole in 1981, their technologies and solutions have influenced life-changing research and outcomes. Thousands of life science experts worldwide rely on SCIEX to get the answers they can trust.
Download the Application Note for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version